Page last updated: 2024-09-03

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetic Nephropathies

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JH; Han, HJ; Kim, DI; Lim, SK; Park, MJ; Park, SH; Yoon, KC1

Other Studies

1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetic Nephropathies

ArticleYear
High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy.
    The Journal of biological chemistry, 2014, May-09, Volume: 289, Issue:19

    Topics: Acetylglucosamine; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta-N-Acetylhexosaminidases; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Gene Expression Regulation, Enzymologic; Glucose; HEK293 Cells; Humans; Lipogenesis; Mesangial Cells; Oximes; Phenylcarbamates; Rats; Sweetening Agents; Triglycerides

2014